Literature DB >> 9457459

Risk factors in ocular hypertension.

G Georgopoulos1, D Andreanos, N Liokis, D Papakonstantinou, J Vergados, G Theodossiadis.   

Abstract

The aim of the study was to determine whether certain factors are related to an increased risk of developing open-angle glaucoma. A total of 345 untreated glaucoma suspects with intraocular pressure (IOP) > or = 21 mmHg, cup to disc ratio 0.4 or less and no visual field defects, were followed up for 6 to 8 years (mean 7.3). During the follow-up 71 patients developed established glaucoma and were compared to the remaining 274 patients. The following factors were analysed: age, family history of glaucoma, IOP, Humphrey 30-2 visual fields, optic disc appearance, myopia, exfoliation, arterial hypertension and diabetes. Analysis yielded statistically significant results regarding a number of these factors in the patients who subsequently developed open-angle glaucoma. A significant association with the subsequent development of field loss in ocular hypertension (OHT) included: heredity (p < 0.001), age > or = 60 years (p = 0.013), axial myopia (0.001 < p < 0.01) and arterial hypertension (p = 0.05). About 20% of patients with ocular hypertension developed glaucoma over a period of seven years. Risk factors such as heredity, age, myopia and arterial hypertension, among others, must be considered in the follow-up of glaucoma suspects.

Entities:  

Mesh:

Year:  1997        PMID: 9457459     DOI: 10.1177/112067219700700409

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  6 in total

1.  [Glaucoma and ocular hypertension in primary care].

Authors:  J Jaén Díaz; I Sanz Alcolea; F López De Castro; T Pérez Martínez; P Ortega Campos; R Corral Morales
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

2.  Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

Authors:  Mae O Gordon; Valter Torri; Stefano Miglior; Julia A Beiser; Irene Floriani; J Philip Miller; Feng Gao; Ingrid Adamsons; Davide Poli; Ralph B D'Agostino; Michael A Kass
Journal:  Ophthalmology       Date:  2006-11-07       Impact factor: 12.079

3.  Comparison of newly diagnosed ocular hypertension and open-angle glaucoma: ocular variables, risk factors, and disease severity.

Authors:  Yvonne M Buys; Paul Harasymowycz; Rania Gaspo; Kenneth Kwok; Cindy M L Hutnik; Pierre Blondeau; Catherine M Birt; Robert L G Piemontesi; Lisa F Gould; Mark R Lesk; Iqbal K Ahmed
Journal:  J Ophthalmol       Date:  2011-08-18       Impact factor: 1.909

4.  Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma.

Authors:  Dimitris Papaconstantinou; Ilias Georgalas; George Kalantzis; Efthimios Karmiris; Chrysanthi Koutsandrea; Andreas Diagourtas; Ioannis Ladas; Gerasimos Georgopoulos
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection.

Authors:  Yasunari Munemasa; Yasushi Kitaoka
Journal:  Front Cell Neurosci       Date:  2013-01-09       Impact factor: 5.505

6.  Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation.

Authors:  Jorge L Cueva Vargas; Ingrid K Osswald; Nicolas Unsain; Mark R Aurousseau; Philip A Barker; Derek Bowie; Adriana Di Polo
Journal:  J Neurosci       Date:  2015-09-02       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.